Literature DB >> 22309193

Mechanism and specificity of the human paracaspase MALT1.

Janna Hachmann1, Scott J Snipas, Bram J van Raam, Erik M Cancino, Emily J Houlihan, Marcin Poreba, Paulina Kasperkiewicz, Marcin Drag, Guy S Salvesen.   

Abstract

The paracaspase domain of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) is a component of a gene translocation fused to the N-terminal domains of the cellular inhibitor of apoptosis protein 2. The paracaspase itself, commonly known as MALT1, participates in the NF-κB (nuclear factor κB) pathway, probably by driving survival signals downstream of the B-cell antigen receptor through MALT1 proteolytic activity. We have developed methods for the expression and purification of recombinant full-length MALT1 and its constituent catalytic domain alone. Both are activated by dimerization without cleavage, with a similar dimerization barrier to the distantly related cousins, the apical caspases. By using positional-scanning peptidyl substrate libraries we demonstrate that the activity and specificity of full-length MALT1 is recapitulated by the catalytic domain alone, showing a stringent requirement for cleaving after arginine, and with striking peptide length constraints for efficient hydrolysis. Rates of cleavage (kcat/Km values) of optimal peptidyl substrates are in the same order (10(3)-10(4) M(-1)·s(-1)) as for a putative target protein CYLD. Thus MALT1 has many similarities to caspase 8, even cleaving the putative target protein CYLD with comparable efficiencies, but with diametrically opposite primary substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309193      PMCID: PMC3304489          DOI: 10.1042/BJ20120035

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.

Authors:  P C Lucas; M Yonezumi; N Inohara; L M McAllister-Lucas; M E Abazeed; F F Chen; S Yamaoka; M Seto; G Nunez
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

2.  Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding.

Authors:  J Chai; Q Wu; E Shiozaki; S M Srinivasula; E S Alnemri; Y Shi
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

3.  Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma.

Authors:  A G Uren; K O'Rourke; L A Aravind; M T Pisabarro; S Seshagiri; E V Koonin; V M Dixit
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

4.  CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.

Authors:  Joel L Pomerantz; Elissa M Denny; David Baltimore
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

5.  Structural basis for the activation of human procaspase-7.

Authors:  S J Riedl; P Fuentes-Prior; M Renatus; N Kairies; S Krapp; R Huber; G S Salvesen; W Bode
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

6.  A unified model for apical caspase activation.

Authors:  Kelly M Boatright; Martin Renatus; Fiona L Scott; Sabina Sperandio; Hwain Shin; Irene M Pedersen; Jean Ehrland Ricci; Wade A Edris; Daniel P Sutherlin; Douglas R Green; Guy S Salvesen
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

7.  Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8.

Authors:  H R Stennicke; M Renatus; M Meldal; G S Salvesen
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

8.  Expedient solid-phase synthesis of fluorogenic protease substrates using the 7-amino-4-carbamoylmethylcoumarin (ACC) fluorophore.

Authors:  Dustin J Maly; Francesco Leonetti; Bradley J Backes; Deborah S Dauber; Jennifer L Harris; Charles S Craik; Jonathan A Ellman
Journal:  J Org Chem       Date:  2002-02-08       Impact factor: 4.354

9.  A requirement for CARMA1 in TCR-induced NF-kappa B activation.

Authors:  Donghai Wang; Yun You; Sara M Case; Linda M McAllister-Lucas; Lin Wang; Peter S DiStefano; Gabriel Nuñez; John Bertin; Xin Lin
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

10.  CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation.

Authors:  Olivier Gaide; Benoît Favier; Daniel F Legler; David Bonnet; Brian Brissoni; Salvatore Valitutti; Claude Bron; Jürg Tschopp; Margot Thome
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

View more
  34 in total

Review 1.  Metacaspases versus caspases in development and cell fate regulation.

Authors:  E A Minina; N S Coll; H Tuominen; P V Bozhkov
Journal:  Cell Death Differ       Date:  2017-02-24       Impact factor: 15.828

2.  MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo.

Authors:  Lorena Fontan; Chenghua Yang; Venkataraman Kabaleeswaran; Laurent Volpon; Michael J Osborne; Elena Beltran; Monica Garcia; Leandro Cerchietti; Rita Shaknovich; Shao Ning Yang; Fang Fang; Randy D Gascoyne; Jose Angel Martinez-Climent; J Fraser Glickman; Katherine Borden; Hao Wu; Ari Melnick
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

Review 3.  Orthocaspase and toxin-antitoxin loci rubbing shoulders in the genome of Microcystis aeruginosa PCC 7806.

Authors:  Marina Klemenčič; Marko Dolinar
Journal:  Curr Genet       Date:  2016-03-11       Impact factor: 3.886

Review 4.  The CBM signalosome: potential therapeutic target for aggressive lymphoma?

Authors:  Chenghua Yang; Liron David; Qi Qiao; Ermelinda Damko; Hao Wu
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

5.  Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domain.

Authors:  Rebekka Schairer; Gareth Hall; Ming Zhang; Richard Cowan; Roberta Baravalle; Frederick W Muskett; Peter J Coombs; Chido Mpamhanga; Lisa R Hale; Barbara Saxty; Justyna Iwaszkiewicz; Chantal Décaillet; Mai Perroud; Mark D Carr; Margot Thome
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-24       Impact factor: 11.205

6.  MALT1 is not alone after all: identification of novel paracaspases.

Authors:  Paco Hulpiau; Yasmine Driege; Jens Staal; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2015-09-16       Impact factor: 9.261

Review 7.  A primer on caspase mechanisms.

Authors:  Monica L Gonzalez Ramirez; Guy S Salvesen
Journal:  Semin Cell Dev Biol       Date:  2018-01-12       Impact factor: 7.727

8.  Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.

Authors:  Lorena Fontán; Qi Qiao; John M Hatcher; Gabriella Casalena; Ilkay Us; Matt Teater; Matt Durant; Guangyan Du; Min Xia; Natalia Bilchuk; Spandan Chennamadhavuni; Giuseppe Palladino; Giorgio Inghirami; Ulrike Philippar; Hao Wu; David A Scott; Nathanael S Gray; Ari Melnick
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

9.  Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.

Authors:  Qi Qiao; Chenghua Yang; Chao Zheng; Lorena Fontán; Liron David; Xiong Yu; Clay Bracken; Monica Rosen; Ari Melnick; Edward H Egelman; Hao Wu
Journal:  Mol Cell       Date:  2013-09-26       Impact factor: 17.970

Review 10.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.